Yunnan Botanee Bio-Technology GroupLTD Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St · 10/26 00:58

Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Third Quarter 2024 Results

Key Financial Results

  • Revenue: CN¥1.21b (up 14% from 3Q 2023).
  • Net loss: CN¥69.0m (down by 153% from CN¥129.2m profit in 3Q 2023).
  • CN¥0.17 loss per share (down from CN¥0.31 profit in 3Q 2023).
earnings-and-revenue-growth
SZSE:300957 Earnings and Revenue Growth October 26th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Yunnan Botanee Bio-Technology GroupLTD Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 1.8%. Earnings per share (EPS) was also behind analyst expectations.

Looking ahead, revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Personal Products industry in China.

Performance of the Chinese Personal Products industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 4 warning signs for Yunnan Botanee Bio-Technology GroupLTD that you need to be mindful of.